Get the Stockscreener App
5.63
0.88%
-0.05
After Hours:
5.75
0.12
+2.13%
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Forecast
The Biodexa Pharmaceuticals Plc Adr (BDRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.4417, representing a +32.18% increase from the current price of $5.63. The highest analyst price target is $8.2955, and the lowest is $6.5879.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BDRX Price Target
Average 8.1234
(+44.29% Upside)
Is Biodexa Pharmaceuticals Plc Adr (BDRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.19 | Neutral |
| STOCH(9,6) | 26.13 | Neutral |
| STOCHRSI(14) | 0.8805 | Buy |
| MACD(12,26) | -0.5414 | Buy |
| ADX(14) | 24.70 | Neutral |
| William %R | -93.33 | Buy |
| CCI(14) | -106.37 | Sell |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.2735
Sell
|
6.053
Sell
|
| MA20 |
6.0077
Sell
|
6.3259
Sell
|
| MA50 |
7.9181
Sell
|
8.5584
Sell
|
| MA100 |
13.73
Sell
|
13.88
Sell
|
| MA200 |
22.17
Sell
|
30.49
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BDRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on BDRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.19 indicates that BDRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.13 indicates that BDRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.8805 indicates that BDRX is oversold. This suggests that BDRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.7 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -106.37 indicates that BDRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term BDRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Biodexa Pharmaceuticals Plc Adr financial reports and earnings history, Biodexa Pharmaceuticals Plc Adr (BDRX) stock could reach $23.68 by 2030, $64.36 by 2040 and $118.45 by 2050. See the projected annual prices until 2050 of the Biodexa Pharmaceuticals Plc Adr stock below:
- Biodexa Pharmaceuticals Plc Adr (BDRX) is expected to reach an average price of $42.37 in 2035, with a high prediction of $42.70 and a low estimate of $40.35. This indicates an $652.50% rise from the last recorded price of $5.63.
- Biodexa Pharmaceuticals Plc Adr (BDRX) stock is projected to chart a bullish course in 2040, with an average price target of $64.18, representing an $1,040% surge from its current level. The forecast ranges from a conservative $61.30 to a sky-high $64.36.
- Our analysts predict Biodexa Pharmaceuticals Plc Adr (BDRX) to jump 1,499% by 2045, soaring from $85.98 to an average price of $90.05, potentially reaching $90.43. While $85.98 is the low estimate, the potential upside is significant.
- Biodexa Pharmaceuticals Plc Adr (BDRX) stock is expected to climb by 2050, reaching an average of $118.35, a $2,002% jump from its current level. However, a wide range of estimates exists, with high and low targets of $118.45 and $113.18, respectively, highlighting the market's uncertainty.
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Year by Year Forecast
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Price Forecast for 2024
Our forecast for BDRX stock price in 2024 now indicates an average price target of $6.488 with a high forecast of $12.31 and a low forecast of $0.67. The average prediction reflects an increase of +15.24% from the last recorded price of $5.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $6.8928 | $6.5879 | $8.2955 | +22.43% |
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Price Forecast for 2025
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) is expected to reach an average price of $8.653 in 2025, with a high prediction of $14.97 and a low estimate of $2.3342. This indicates an +53.69% rise from the last recorded price of $5.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.575 | $5.7953 | $12.56 | +34.55% |
| February, 2025 | $6.7948 | $6.0924 | $8.0175 | +20.69% |
| March, 2025 | $6.3146 | $6.0422 | $6.9273 | +12.16% |
| April, 2025 | $6.2568 | $5.832 | $6.8044 | +11.13% |
| May, 2025 | $6.2266 | $6.0793 | $6.3866 | +10.60% |
| June, 2025 | $6.2635 | $5.9208 | $7.2015 | +11.25% |
| July, 2025 | $2.3921 | $2.3342 | $7.2313 | -57.51% |
| August, 2025 | $2.9634 | $2.5175 | $2.9838 | -47.36% |
| September, 2025 | $3.3906 | $3.0563 | $3.3933 | -39.78% |
| October, 2025 | $8.3778 | $3.5215 | $9.7777 | +48.81% |
| November, 2025 | $10.06 | $7.6827 | $13.91 | +78.64% |
| December, 2025 | $13.32 | $9.6223 | $14.97 | +136.62% |
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Price Forecast for 2026
The predicted value for Biodexa Pharmaceuticals Plc Adr (BDRX) in 2026 is set at an average of $9.8608. Estimates vary from a peak of $16.32 to a trough of $3.4063, indicating an +75.15% surge from the present price of $5.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.49 | $10.94 | $13.52 | +104.11% |
| February, 2026 | $10.12 | $9.8912 | $12.16 | +79.77% |
| March, 2026 | $9.5105 | $9.3305 | $10.89 | +68.93% |
| April, 2026 | $10.71 | $9.5195 | $16.32 | +90.32% |
| May, 2026 | $10.91 | $10.13 | $11.33 | +93.86% |
| June, 2026 | $10.56 | $10.37 | $11.07 | +87.64% |
| July, 2026 | $10.95 | $10.45 | $11.50 | +94.47% |
| August, 2026 | $11.31 | $11.11 | $11.48 | +100.86% |
| September, 2026 | $12.28 | $11.12 | $12.72 | +118.16% |
| October, 2026 | $3.708 | $3.4063 | $12.77 | -34.14% |
| November, 2026 | $4.502 | $3.872 | $4.5579 | -20.04% |
| December, 2026 | $5.4797 | $4.6413 | $5.5017 | -2.67% |
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Biodexa Pharmaceuticals Plc Adr (BDRX) is $12.87, with a high forecast of $20.07 and a low forecast of $5.667. This indicates an +128.55% increase from the last price of $5.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.65 | $5.667 | $16.00 | +106.91% |
| February, 2027 | $13.53 | $10.69 | $16.49 | +140.29% |
| March, 2027 | $14.02 | $12.26 | $17.64 | +148.94% |
| April, 2027 | $14.07 | $13.75 | $16.33 | +149.99% |
| May, 2027 | $13.78 | $12.99 | $14.79 | +144.83% |
| June, 2027 | $13.83 | $12.87 | $14.35 | +145.66% |
| July, 2027 | $14.88 | $14.46 | $20.07 | +164.30% |
| August, 2027 | $14.79 | $14.18 | $15.37 | +162.68% |
| September, 2027 | $15.18 | $14.71 | $15.87 | +169.55% |
| October, 2027 | $16.10 | $15.40 | $16.19 | +185.88% |
| November, 2027 | $17.22 | $16.20 | $17.60 | +205.94% |
| December, 2027 | $18.20 | $16.89 | $18.30 | +223.29% |
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Price Forecast for 2028
In 2028, Biodexa Pharmaceuticals Plc Adr (BDRX) is projected to reach an average price of $14.15, with a high projection of $23.82 and a low estimate of $4.4784. This indicates an +151.32% rise from the last price of $5.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.0942 | $4.4784 | $18.41 | -9.52% |
| February, 2028 | $6.1587 | $5.3498 | $6.2311 | +9.39% |
| March, 2028 | $7.543 | $6.3969 | $7.5628 | +33.98% |
| April, 2028 | $14.24 | $7.8283 | $18.09 | +152.84% |
| May, 2028 | $15.00 | $14.23 | $18.86 | +166.50% |
| June, 2028 | $17.79 | $15.01 | $20.30 | +216.04% |
| July, 2028 | $16.31 | $16.09 | $18.36 | +189.74% |
| August, 2028 | $17.28 | $16.44 | $18.03 | +206.95% |
| September, 2028 | $18.63 | $16.40 | $23.82 | +230.91% |
| October, 2028 | $18.74 | $18.22 | $19.71 | +232.85% |
| November, 2028 | $19.53 | $18.89 | $19.74 | +246.86% |
| December, 2028 | $20.33 | $19.51 | $20.89 | +261.06% |
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Price Forecast for 2029
The 2029 price forecast for Biodexa Pharmaceuticals Plc Adr Stock (BDRX) is $16.56 on average, with a high prediction of $27.57 and a low estimate of $5.5505. This represents an +194.17% increase from the previous price of $5.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $21.40 | $20.38 | $21.56 | +280.04% |
| February, 2029 | $22.30 | $21.52 | $22.81 | +296.14% |
| March, 2029 | $23.24 | $22.43 | $24.04 | +312.71% |
| April, 2029 | $6.6621 | $5.5505 | $6.6892 | +18.33% |
| May, 2029 | $8.3456 | $7.0224 | $8.3483 | +48.24% |
| June, 2029 | $9.7759 | $8.6939 | $9.7854 | +73.64% |
| July, 2029 | $16.98 | $10.13 | $20.17 | +201.53% |
| August, 2029 | $17.99 | $16.75 | $21.24 | +219.49% |
| September, 2029 | $20.60 | $18.10 | $22.97 | +265.83% |
| October, 2029 | $19.86 | $19.19 | $21.28 | +252.71% |
| November, 2029 | $20.12 | $19.86 | $21.28 | +257.31% |
| December, 2029 | $22.88 | $20.34 | $27.57 | +306.31% |
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) Price Forecast for 2030
Biodexa Pharmaceuticals Plc Adr Stock (BDRX) is expected to reach an average price of $18.15 in 2030, with a high forecast of $29.68 and a low forecast of $6.6226. This signifies an +222.41% surge from the last price of $5.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $23.48 | $22.26 | $23.68 | +316.99% |
| February, 2030 | $24.00 | $23.31 | $24.35 | +326.20% |
| March, 2030 | $25.32 | $24.15 | $25.58 | +349.81% |
| April, 2030 | $26.45 | $25.44 | $26.61 | +369.86% |
| May, 2030 | $27.85 | $26.65 | $28.02 | +394.61% |
| June, 2030 | $6.6805 | $6.6226 | $29.68 | +18.66% |
| July, 2030 | $8.805 | $7.0957 | $8.8609 | +56.39% |
| August, 2030 | $10.42 | $9.1617 | $10.43 | +85.11% |
| September, 2030 | $16.43 | $10.85 | $17.83 | +191.89% |
| October, 2030 | $20.66 | $16.03 | $23.62 | +266.91% |
| November, 2030 | $23.99 | $19.83 | $25.64 | +326.03% |
| December, 2030 | $23.31 | $22.03 | $24.76 | +314.11% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):